Date Log
Submitted
June 2, 2022
Published
June 2, 2022
Quality assurance of clinical pharmacy services in a multi-speciality tertiary care hospital
Corresponding Author(s) : Lawadia Jyothi
jyothichauhan30@gmail.com
International Journal of Allied Medical Sciences and Clinical Research,
Vol. 10 No. 2 (2022): 2022 Volume - 10 Issue - 2
Abstract
Aim
The aim of this study is to evaluate quality assurance program in clinical pharmacy services of a multi-speciality tertiary care hospital.
Methodology
The present prospective study was conducted at Aware Gleneagles Global Hospitals. The study involved assessment of QAP and QI from November 2021 – April 2022. Institutional ethical clearance was taken with approval letter.
The check list was adapted from National Accreditation Board for Hospitals and Health care professionals. The data was collected by utilising check list and the data collected was analysed using Microsoft Excel, Microsoft Data Analysis Pack Tool, Microsoft Word.
Results
A total of 36 parameters were evaluated to assess the execution of QAP being implemented in the clinical pharmacy services. The existing QAP in the clinical pharmacy services was assessed in terms of structure, process and outcome. We found that most of the processes were in place as per the defined standards. The overall trend analysis of scoring showed a consistent and good performance, though there were few areas where there was scope for improvement.
Conclusion
The next few years will witness much experimentation in QA process and exciting new opportunities for pharmacist as more active participants in patient care. The study recommended the areas that have to be improved so the same will be useful to us to modify or practice with clinicians.
The aim of this study is to evaluate quality assurance program in clinical pharmacy services of a multi-speciality tertiary care hospital.
Methodology
The present prospective study was conducted at Aware Gleneagles Global Hospitals. The study involved assessment of QAP and QI from November 2021 – April 2022. Institutional ethical clearance was taken with approval letter.
The check list was adapted from National Accreditation Board for Hospitals and Health care professionals. The data was collected by utilising check list and the data collected was analysed using Microsoft Excel, Microsoft Data Analysis Pack Tool, Microsoft Word.
Results
A total of 36 parameters were evaluated to assess the execution of QAP being implemented in the clinical pharmacy services. The existing QAP in the clinical pharmacy services was assessed in terms of structure, process and outcome. We found that most of the processes were in place as per the defined standards. The overall trend analysis of scoring showed a consistent and good performance, though there were few areas where there was scope for improvement.
Conclusion
The next few years will witness much experimentation in QA process and exciting new opportunities for pharmacist as more active participants in patient care. The study recommended the areas that have to be improved so the same will be useful to us to modify or practice with clinicians.
Keywords
Quality assurance
clinical pharmacy
Management of medication
National Accreditation Board of Hospitals
Lawadia Jyothi, G Sai Naga Akshara, B. Naresh, P. Sowmya, & Shiv Kumar Shete. (2022). Quality assurance of clinical pharmacy services in a multi-speciality tertiary care hospital. International Journal of Allied Medical Sciences and Clinical Research, 10(2), 187–195. https://doi.org/10.61096/ijamscr.v10.iss2.2022.187-195
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
References
-
1. Swathi KN. N Satish raju, Doddamani Praveen, NM Suma. Quality assurance program in clinical biochemistry laboratory at a multispecialty tertiary care hospitals, with special reference to quality indicators. Clinical Ppharmacy Ddefined (Ppharmacotherapy 2008; 28(6):816--817).
2. Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155-9. doi: 10.5001/omj.2011.38, PMID 22043406, Google Scholar.
3. Pushkin R, Frassetto L, Tsourounis C, Segal ES, Kim S. Improving the reporting of adverse drug reactions in the hospital setting. Postgrad Med. 2010;122(6):154-64. doi: 10.3810/pgm.2010.11.2233, PMID 21084792.
4. Moride Y, Haramburu F, Requejo AA, Bégaud B. Underreporting of adverse drug reactions in general practice. Br J Clin Pharmacol. 1997;43(2):177-81. doi: 10.1046/j.1365-2125.1997.05417.x.
5. Rao P, George B. Assessment and evaluation of drug information services provided in a South Indian teaching hospital. Indian J Pharmacol. 2005;37(5):315-8. doi: 10.4103/0253-7613.16856.
6. Hugman B. Healthcare communication. Philadelphia: pharmaceutical press; 2009. p. 80-2.
7. Berger BA. Communication skills for pharmacist. 3rd ed. Washington, DC: American pharmacists Association; 2009.
8. Hassan khan M, Abbas A. The importance of clinical pharmacist in health care system. The international weekly journal for medicine. Med Sci. 2014;11(44, August 27):80-1.
9. Ahuja J, Gupta M, Gupta AK, Kohli K. Pharmacoeconomics. Natl Med J India. 2004;17(2):80-3. PMID 15141600.
10. Ashavaid TF, Dheraj AJ. Therapeutic drug monitoring-A review. Indian J Clin Biochem. 1999;14(1):91-4. doi: 10.1007/BF02869153, PMID 23105204.
11. Patel H, Churi S, Gurumurthy PS, Madhan R. Quality Assurance of Adverse drug reactions Reporting and monitoring by clinical pharmacist in a Tertiary Care Teaching Hospital. IJOPP. 2016;9(1):26-31. doi: 10.5530/ijopp.9.1.6.
12. Rotta I, Salgado TM, Silva ML, Cassyano J. Correr, Fernando Fernandez-L limos. Eff Clin Pharm Serv Overview Syst Rev (2000-2010). 2015.
13. Eriksson T. To develop a systematic patient focused clinical pharmacy services. The Lund Integrated Medicines Management model. Eur J Hosp Pharm Sci Pract. 2014;21(2).
14. Tuffaha HW, Koopmans SM. Development and Implementation of a method for characterizing Clinical Pharmacy Interventions and Medication use in cancer center. J Oncol Pharm Pract. 2012;18(2):180-5. doi: 10.1177/1078155211416529, PMID 21862687.
15. Williams A, Manias E, Walker R. Interventions to improve Medication adherence in people with Multiple Chronic conditions; systematic review. J Adv Nurs. 2008;63(2):132-43. doi: 10.1111/j.1365-2648.2008.04656.x, PMID 18537843.
16. Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32(2):113-21. doi: 10.1111/j.1365-2710.2007.00793.x.
17. Grasso BC, Genest R, Jordan CW, Bates DW. Use of chart and record reviews to detect medication errors in a state psychiatric hospital. Psychiatr Serv. 2003;54(5):677-81. doi: 10.1176/appi.ps.54.5.677, PMID 12719497.
18. De Vries ST, Harrison J, Revelle P, Ptaszynska-Neophytou A, Radecka A, Ragunathan G et al. Use of a Patient-friendly terms list in the Adverse Drug Reactions Report form: A Database study. Drug Saf. 2019;42(7):881-6. doi: 10.1007/s40264-019-00800-x, PMID 30725337.
References
1. Swathi KN. N Satish raju, Doddamani Praveen, NM Suma. Quality assurance program in clinical biochemistry laboratory at a multispecialty tertiary care hospitals, with special reference to quality indicators. Clinical Ppharmacy Ddefined (Ppharmacotherapy 2008; 28(6):816--817).
2. Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155-9. doi: 10.5001/omj.2011.38, PMID 22043406, Google Scholar.
3. Pushkin R, Frassetto L, Tsourounis C, Segal ES, Kim S. Improving the reporting of adverse drug reactions in the hospital setting. Postgrad Med. 2010;122(6):154-64. doi: 10.3810/pgm.2010.11.2233, PMID 21084792.
4. Moride Y, Haramburu F, Requejo AA, Bégaud B. Underreporting of adverse drug reactions in general practice. Br J Clin Pharmacol. 1997;43(2):177-81. doi: 10.1046/j.1365-2125.1997.05417.x.
5. Rao P, George B. Assessment and evaluation of drug information services provided in a South Indian teaching hospital. Indian J Pharmacol. 2005;37(5):315-8. doi: 10.4103/0253-7613.16856.
6. Hugman B. Healthcare communication. Philadelphia: pharmaceutical press; 2009. p. 80-2.
7. Berger BA. Communication skills for pharmacist. 3rd ed. Washington, DC: American pharmacists Association; 2009.
8. Hassan khan M, Abbas A. The importance of clinical pharmacist in health care system. The international weekly journal for medicine. Med Sci. 2014;11(44, August 27):80-1.
9. Ahuja J, Gupta M, Gupta AK, Kohli K. Pharmacoeconomics. Natl Med J India. 2004;17(2):80-3. PMID 15141600.
10. Ashavaid TF, Dheraj AJ. Therapeutic drug monitoring-A review. Indian J Clin Biochem. 1999;14(1):91-4. doi: 10.1007/BF02869153, PMID 23105204.
11. Patel H, Churi S, Gurumurthy PS, Madhan R. Quality Assurance of Adverse drug reactions Reporting and monitoring by clinical pharmacist in a Tertiary Care Teaching Hospital. IJOPP. 2016;9(1):26-31. doi: 10.5530/ijopp.9.1.6.
12. Rotta I, Salgado TM, Silva ML, Cassyano J. Correr, Fernando Fernandez-L limos. Eff Clin Pharm Serv Overview Syst Rev (2000-2010). 2015.
13. Eriksson T. To develop a systematic patient focused clinical pharmacy services. The Lund Integrated Medicines Management model. Eur J Hosp Pharm Sci Pract. 2014;21(2).
14. Tuffaha HW, Koopmans SM. Development and Implementation of a method for characterizing Clinical Pharmacy Interventions and Medication use in cancer center. J Oncol Pharm Pract. 2012;18(2):180-5. doi: 10.1177/1078155211416529, PMID 21862687.
15. Williams A, Manias E, Walker R. Interventions to improve Medication adherence in people with Multiple Chronic conditions; systematic review. J Adv Nurs. 2008;63(2):132-43. doi: 10.1111/j.1365-2648.2008.04656.x, PMID 18537843.
16. Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32(2):113-21. doi: 10.1111/j.1365-2710.2007.00793.x.
17. Grasso BC, Genest R, Jordan CW, Bates DW. Use of chart and record reviews to detect medication errors in a state psychiatric hospital. Psychiatr Serv. 2003;54(5):677-81. doi: 10.1176/appi.ps.54.5.677, PMID 12719497.
18. De Vries ST, Harrison J, Revelle P, Ptaszynska-Neophytou A, Radecka A, Ragunathan G et al. Use of a Patient-friendly terms list in the Adverse Drug Reactions Report form: A Database study. Drug Saf. 2019;42(7):881-6. doi: 10.1007/s40264-019-00800-x, PMID 30725337.
2. Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155-9. doi: 10.5001/omj.2011.38, PMID 22043406, Google Scholar.
3. Pushkin R, Frassetto L, Tsourounis C, Segal ES, Kim S. Improving the reporting of adverse drug reactions in the hospital setting. Postgrad Med. 2010;122(6):154-64. doi: 10.3810/pgm.2010.11.2233, PMID 21084792.
4. Moride Y, Haramburu F, Requejo AA, Bégaud B. Underreporting of adverse drug reactions in general practice. Br J Clin Pharmacol. 1997;43(2):177-81. doi: 10.1046/j.1365-2125.1997.05417.x.
5. Rao P, George B. Assessment and evaluation of drug information services provided in a South Indian teaching hospital. Indian J Pharmacol. 2005;37(5):315-8. doi: 10.4103/0253-7613.16856.
6. Hugman B. Healthcare communication. Philadelphia: pharmaceutical press; 2009. p. 80-2.
7. Berger BA. Communication skills for pharmacist. 3rd ed. Washington, DC: American pharmacists Association; 2009.
8. Hassan khan M, Abbas A. The importance of clinical pharmacist in health care system. The international weekly journal for medicine. Med Sci. 2014;11(44, August 27):80-1.
9. Ahuja J, Gupta M, Gupta AK, Kohli K. Pharmacoeconomics. Natl Med J India. 2004;17(2):80-3. PMID 15141600.
10. Ashavaid TF, Dheraj AJ. Therapeutic drug monitoring-A review. Indian J Clin Biochem. 1999;14(1):91-4. doi: 10.1007/BF02869153, PMID 23105204.
11. Patel H, Churi S, Gurumurthy PS, Madhan R. Quality Assurance of Adverse drug reactions Reporting and monitoring by clinical pharmacist in a Tertiary Care Teaching Hospital. IJOPP. 2016;9(1):26-31. doi: 10.5530/ijopp.9.1.6.
12. Rotta I, Salgado TM, Silva ML, Cassyano J. Correr, Fernando Fernandez-L limos. Eff Clin Pharm Serv Overview Syst Rev (2000-2010). 2015.
13. Eriksson T. To develop a systematic patient focused clinical pharmacy services. The Lund Integrated Medicines Management model. Eur J Hosp Pharm Sci Pract. 2014;21(2).
14. Tuffaha HW, Koopmans SM. Development and Implementation of a method for characterizing Clinical Pharmacy Interventions and Medication use in cancer center. J Oncol Pharm Pract. 2012;18(2):180-5. doi: 10.1177/1078155211416529, PMID 21862687.
15. Williams A, Manias E, Walker R. Interventions to improve Medication adherence in people with Multiple Chronic conditions; systematic review. J Adv Nurs. 2008;63(2):132-43. doi: 10.1111/j.1365-2648.2008.04656.x, PMID 18537843.
16. Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32(2):113-21. doi: 10.1111/j.1365-2710.2007.00793.x.
17. Grasso BC, Genest R, Jordan CW, Bates DW. Use of chart and record reviews to detect medication errors in a state psychiatric hospital. Psychiatr Serv. 2003;54(5):677-81. doi: 10.1176/appi.ps.54.5.677, PMID 12719497.
18. De Vries ST, Harrison J, Revelle P, Ptaszynska-Neophytou A, Radecka A, Ragunathan G et al. Use of a Patient-friendly terms list in the Adverse Drug Reactions Report form: A Database study. Drug Saf. 2019;42(7):881-6. doi: 10.1007/s40264-019-00800-x, PMID 30725337.
